However, several studies have reported that circulating tumor cells from cancer patients express the HA receptor CD44 (Grillet et al., 2017) and can be captured from circulation by adhering to HA, a process that is mediated by HA receptors (Xu et al., 2017). This evidence concerns the gene CD44 and cancer.